Page last updated: 2024-10-31

methoxyamine and Astrocytoma, Grade IV

methoxyamine has been researched along with Astrocytoma, Grade IV in 2 studies

methoxyamine: analytical reagent for aldehydes and ketones; strong irritant, can probably produce methemoglobinemia; RN given refers to parent cpd; structure

Research Excerpts

ExcerptRelevanceReference
" The aim of this study was to evaluate the cellular responses to temozolomide treatment associated with methoxyamine (blocker of base excision repair) in glioblastoma cell lines, in order to test the hypothesis that the blockage of base excision repair pathway might sensitize glioblastoma cells to temozolomide."7.79Methoxyamine sensitizes the resistant glioblastoma T98G cell line to the alkylating agent temozolomide. ( Montaldi, AP; Sakamoto-Hojo, ET, 2013)
" The aim of this study was to evaluate the cellular responses to temozolomide treatment associated with methoxyamine (blocker of base excision repair) in glioblastoma cell lines, in order to test the hypothesis that the blockage of base excision repair pathway might sensitize glioblastoma cells to temozolomide."3.79Methoxyamine sensitizes the resistant glioblastoma T98G cell line to the alkylating agent temozolomide. ( Montaldi, AP; Sakamoto-Hojo, ET, 2013)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Goellner, EM1
Grimme, B1
Brown, AR1
Lin, YC1
Wang, XH1
Sugrue, KF1
Mitchell, L1
Trivedi, RN1
Tang, JB1
Sobol, RW1
Montaldi, AP1
Sakamoto-Hojo, ET1

Other Studies

2 other studies available for methoxyamine and Astrocytoma, Grade IV

ArticleYear
Overcoming temozolomide resistance in glioblastoma via dual inhibition of NAD+ biosynthesis and base excision repair.
    Cancer research, 2011, Mar-15, Volume: 71, Issue:6

    Topics: Acrylamides; Adenosine Triphosphate; Antineoplastic Agents, Alkylating; Cell Line, Tumor; Cell Survi

2011
Methoxyamine sensitizes the resistant glioblastoma T98G cell line to the alkylating agent temozolomide.
    Clinical and experimental medicine, 2013, Volume: 13, Issue:4

    Topics: Alkylating Agents; Antineoplastic Agents; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Sur

2013